Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection
Dengue is endemic throughout tropical and subtropical regions of the world. Currently, there is no clinically approved therapeutic drug available for this acute viral infection. Although the first dengue vaccine Dengvaxia has been approved for use in certain countries, it is limited to those without...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
PeerJ Inc.
2018-01-01
|
| Sarja: | PeerJ |
| Aiheet: | |
| Linkit: | https://peerj.com/articles/3939.pdf |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|